Patient Preference and Adherence
Volume 10, 2016 - Issue
Open access
52
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
Lulu K Lee1 Health Outcomes Practice, Kantar Health, New York, NYCorrespondence[email protected]
, Amir Goren1 Health Outcomes Practice, Kantar Health, New York, NY
, Natalie N Boytsov2 US Real World Outcomes Research, Eli Lily & Company, Indianapolis, IN
, Craig F Donatucci2 US Real World Outcomes Research, Eli Lily & Company, Indianapolis, IN
& Kevin T McVary3 Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA
Pages 1205-1215
|
Published online: 12 Jul 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.